ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly non-GAAP effective tax rate (%) (%)
Form 8-K Non-GAAP Reconciliation Schedules
Latest, FY2025
18.4%
Period ended Dec 31, 2025
Change on a year earlier
+1.5 pts
16.9% in FY2024
History
4 years
Since FY2022
Sources
3
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Non-GAAP effective tax rate (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 18.4% | +1.5 pts | Earnings Release (Form 8-K FY2025Q4 EX-99.1) (filed 2026-02-04) ↗ |
| FY2024 | Dec 31, 2024 | 16.9% | -3.2 pts | Earnings Release (Form 8-K FY2024Q4 EX-99.1) (filed 2025-02-06) ↗ |
| FY2023 | Dec 31, 2023 | 20.1% | +9.8 pts | Earnings Release (Form 8-K FY2023Q4 EX-99.1) (filed 2024-02-06) ↗ |
| FY2022 | Dec 31, 2022 | 10.3% | – | Earnings Release (Form 8-K FY2023Q4 EX-99.1) (filed 2024-02-06) ↗ |
Cite this data
StockData. (2026). Eli Lilly Non-GAAP effective tax rate (%) (%), annual FY2022–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/tax_rate_nongaap
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.